Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Parkinson's Disease

Free Subscription 15.07.2019 1 Ann Neurol 1 Brain Res 2 J Neural Transm (Vienna) 1 J Neurochem 4 Mov Disord 1 Neurobiol Dis 3 Neurology 1 Neurosci Lett

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Ann Neurol

1. DEL DIN S, Elshehabi M, Galna B, Hobert M, et al
   Gait analysis with wearables predicts conversion to Parkinson's disease.
   Ann Neurol. 2019 Jul 11. doi: 10.1002/ana.25548.
   PubMed     Text format     Abstract available
   
   

   
   Brain Res

2. JIANG Y, Liu J, Chen L, Jin Y, et al
   Serum secreted miR-137-containing exosomes affects oxidative stress of neurons by regulating OXR1 in Parkinson's disease.
   Brain Res. 2019 Jul 10:146331. doi: 10.1016/j.brainres.2019.146331.
   PubMed     Text format     Abstract available
   
   

   
   J Neural Transm (Vienna)

3. DOS SANTOS AB, Bezerra MA, Rocha ME, Barreto GE, et al
   Higher zinc concentrations in hair of Parkinson's disease are associated with psychotic complications and depression.
   J Neural Transm (Vienna). 2019 Jul 11. pii: 10.1007/s00702-019-02041.
   PubMed     Text format     Abstract available
   
   
4. BARBOSA RP, Mendonca MD, Caetano AP, Lampreia TM, et al
   Cognitive complaints in Parkinson's disease patients: from subjective cognitive complaints to dementia and affective disorders.
   J Neural Transm (Vienna). 2019 Jul 5. pii: 10.1007/s00702-019-02042.
   PubMed     Text format     Abstract available
   
   

   
   J Neurochem

5. VIDYADHARA DJ, Lee JE, Chandra SS
   Role of the Endolysosomal System in Parkinson's disease.
   J Neurochem. 2019 Jul 9. doi: 10.1111/jnc.14820.
   PubMed     Text format     Abstract available
   
   

   
   Mov Disord

6. KELLY MJ, Lawton MA, Baig F, Ruffmann C, et al
   Predictors of motor complications in early Parkinson's disease: A prospective cohort study.
   Mov Disord. 2019 Jul 8. doi: 10.1002/mds.27783.
   PubMed     Text format     Abstract available
   
   
7. OERTEL WH, Henrich MT, Janzen A, Geibl FF, et al
   The locus coeruleus: Another vulnerability target in Parkinson's disease.
   Mov Disord. 2019 Jul 10. doi: 10.1002/mds.27785.
   PubMed     Text format    
   
   
8. EVERS LJW, Krijthe JH, Meinders MJ, Bloem BR, et al
   Measuring Parkinson's disease over time: The real-world within-subject reliability of the MDS-UPDRS.
   Mov Disord. 2019 Jul 10. doi: 10.1002/mds.27790.
   PubMed     Text format     Abstract available
   
   
9. MOOSA S, Martinez-Fernandez R, Elias WJ, Del Alamo M, et al
   The role of high-intensity focused ultrasound as a symptomatic treatment for Parkinson's disease.
   Mov Disord. 2019 Jul 10. doi: 10.1002/mds.27779.
   PubMed     Text format     Abstract available
   
   

   
   Neurobiol Dis

10. CICCHETTI F, David LS, Siddu A, Denis HL, et al
    Cysteamine as a novel disease-modifying compound for Parkinson's disease: Over a decade of research supporting a clinical trial.
    Neurobiol Dis. 2019 Jul 10:104530. doi: 10.1016/j.nbd.2019.104530.
    PubMed     Text format     Abstract available
    
    

    
    Neurology

11. LENKA A, Pagonabarraga J, Pal PK, Bejr-Kasem H, et al
    Minor hallucinations in Parkinson disease: A subtle symptom with major clinical implications.
    Neurology. 2019 Jul 9. pii: WNL.0000000000007913.
    PubMed     Text format     Abstract available
    
    
12. LEE MJ, Pak K, Kim JH, Kim YJ, et al
    Effect of polygenic load on striatal dopaminergic deterioration in Parkinson disease.
    Neurology. 2019 Jul 9. pii: WNL.0000000000007939.
    PubMed     Text format     Abstract available
    
    
13. BARICHELLA M, Cereda E, Pinelli G, Iorio L, et al
    Muscle-targeted nutritional support for rehabilitation in patients with parkinsonian syndrome.
    Neurology. 2019 Jul 5. pii: WNL.0000000000007858.
    PubMed     Text format     Abstract available
    
    

    
    Neurosci Lett

14. HU F, Duan M, Peng N
    Knockdown of TRB3 improved the MPP(+)/MPTP-induced Parkinson's disease through the MAPK and AKT signaling pathways.
    Neurosci Lett. 2019;709:134352.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: